ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 999

Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation

Marie Westby1, Deborah Marshall2, Jane Squire Howden3 and C. Allyson Jones4, 1School of Public Health, University of Alberta, Edmonton, AB, Canada, 2University of Calgary, Calgary, AB, Canada, 3Edmonton Musculoskeletal Centre, Edmonton, AB, Canada, 4Physical Therapy, University of Alberta, Edmonton, AB, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Quality Indicators, rehabilitation and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Rehabilitation before and after total hip (THA) and knee arthroplasty (TKA) surgery has been shown to decrease pain and impairment, and improve mobility, activity and participation. Yet there are reports of marked variation in clinical practices, outcomes and resources allocated for rehabilitation services. This project aimed to develop core sets of quality indicators (QIs) reflecting the minimum acceptable standard of rehabilitation care before and after elective THA and TKA for osteoarthritis.  

Methods: We assembled an 18-member Canada-wide panel of clinicians, researchers and patients and used a modified RAND-UCLA Delphi approach to establish consensus on 82 proposed QIs (40 for THA, 42 for TKA). Indicators were derived from the authors’ previous work and the literature and reflected the rehabilitation continuum (pre-operative, acute care and post-acute up to 1 year post-surgery). Panelists completed 2 rounds of rating using an online survey interspersed by a moderated online discussion forum over a 3-month period. Prior to rating, panelists received a synthesis of high quality evidence (practice guidelines, systematic reviews, randomized controlled trials) supporting each QI. They were instructed to review the evidence before accessing the survey. Each QI was rated for its importance and validity on a 9-point Likert scale. Individual and group ratings from Round 1 were summarized and provided to panelists in order to inform the subsequent online discussion. During Round 2, panelists were asked to participate in the forum anonymously, share their views on the proposed QIs and debate each others’ comments. This was immediately followed by the final round of ratings. Those QIs with median ratings of 7 or higher for both importance and validity, and with no disagreement were included in the final sets. 

Results: Fifteen panelists representing 7 provinces and varied practice settings completed the Delphi process. Of the 82 proposed QIs, 67 (82%) were rated as both important and valid (31 for THA, 36 for TKA). For THA, 14 pre-op, 6 acute and 8 post-acute QIs were accepted. For TKA, 16 pre-op, 10 acute and 8 post-acute indicators were accepted. The majority of these QIs address assessment and screening activities (74%) while the remainder pertain to rehabilitation interventions. Three ‘across-continuum’ QIs were rated appropriate for THA and 2 of 3 for TKA. Engagement was high with 83% of panelists participating in the discussion forum. 

Conclusion: These QIs represent an important first step in addressing rehabilitation practice and outcome variation and will serve as a tool with which to measure, report and benchmark quality of care in patients receiving rehabilitation before and after THA/TKA surgery. Online technology facilitated broad geographical representation, panelist anonymity and engagement, and decreased panelist burden and administration costs compared to the traditional RAND/UCLA method. The QIs will be further tested for reliability and feasibility before being widely disseminated in clinical settings and used to assess care gaps.


Disclosure: M. Westby, None; D. Marshall, CIHR, Arthritis Society, AIHS, CIORA, 2,University of Calgary, 3,Abbvie, 5,Pfizer Inc, 5,Novartis Pharmaceutical Corporation, 5,Johnson & Johnson, 5; J. Squire Howden, None; C. A. Jones, None.

To cite this abstract in AMA style:

Westby M, Marshall D, Squire Howden J, Jones CA. Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/development-of-quality-indicators-for-hip-and-knee-arthroplasty-rehabilitation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-quality-indicators-for-hip-and-knee-arthroplasty-rehabilitation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology